Codexis vs Green Plains
Codexis (CDXS) and Green Plains (GPRE) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $111M
- Last close
- $1.01
- 12 months
- −35.7%
- Market value
- $796M
- Last close
- $11.27
- 12 months
- +13.7%
At a glance
- The biggest part of Codexis's revenue is Research and development revenue (63%); at Green Plains it is Ethanol Production (92%).
- By market value, Green Plains ($796M) is about 7.2 times Codexis ($111M).
- Over the last 12 months Codexis's share price moved −35.7% and Green Plains's +13.7%; against the S&P 500 that is −41.4 points and +8.0 points.
- In their last fiscal years Codexis kept -62.5% of revenue as net income and Green Plains -5.8%.
- In the last 90 days insiders reported 0 open-market purchases at Codexis and 0 at Green Plains; members of Congress disclosed 0 trades in Codexis and 0 in Green Plains.
- Next results: Codexis Mar 9, 2027, Green Plains Feb 3, 2027.
How each one makes money: Codexis revenue · Green Plains revenue
Share prices on one chart
Codexis and Green Plains, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Codexis CDXSNASDAQ · Industrial Organic Chemicals | Green Plains GPRENASDAQ · Industrial Organic Chemicals | |
|---|---|---|
| Size and profitability | ||
| Market value | $111M | $796M |
| Revenue, last fiscal year | $70.4M | $2.09B |
| Net income, last fiscal year | −$44M | −$121M |
| Net marginNet income as a share of revenue | -62.5% | -5.8% |
| Free cash flow | −$23.8M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Codexis different from Green Plains?
Codexis (CDXS) is in Industrial Organic Chemicals on NASDAQ, with $70.4M of revenue in its last fiscal year and a net margin of -62.5%. Green Plains (GPRE) is in Industrial Organic Chemicals on NASDAQ, with $2.09B of revenue in its last fiscal year and a net margin of -5.8%. The biggest part of Codexis's revenue is Research and development revenue (63%); at Green Plains it is Ethanol Production (92%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Codexis and Green Plains compare in size?
Green Plains has the larger market value: Codexis $111M and Green Plains $796M, at the last close.
Whose share price rose more over the last 12 months, CDXS or GPRE?
Over the last 12 months Codexis moved −35.7% and Green Plains +13.7%. Past price moves say nothing about the future.
Which has had more insider buying, Codexis or Green Plains?
Since 2006, Green Plains insiders reported 100 open-market purchases against 78 for Codexis. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CDXS or GPRE?
In the last 12 months, members of Congress disclosed 0 trades in Codexis (CDXS) and 0 in Green Plains (GPRE).
When did insiders last buy CDXS and GPRE?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Codexis pageGreen Plains pageRare insider trades this weekAll comparisons
https://oqro.io/compare/cdxs-vs-gpre

